Form 8-K - Current report:
SEC Accession No. 0001513162-22-000014
Filing Date
2022-02-10
Accepted
2022-02-10 16:04:17
Documents
15
Period of Report
2022-02-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmra-20220208.htm   iXBRL 8-K 34138
6 EXHIBIT 99.1 exhibit99_1.htm EX-99.1 22451
7 GRAPHIC logo.jpg GRAPHIC 5101
  Complete submission text file 0001513162-22-000014.txt   202995

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20220208.xsd EX-101.SCH 3215
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20220208_def.xml EX-101.DEF 10555
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20220208_lab.xml EX-101.LAB 21457
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20220208_pre.xml EX-101.PRE 10917
9 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20220208_htm.xml XML 2443
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 22613856
SIC: 2835 In Vitro & In Vivo Diagnostic Substances